Ibrutix 140 Mg (Ibrutinib) – 120 Capsules

Ibrutix 140 mg is used for the treatment of several types of lymphoma and leukemia. And also  including Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Small Lymphocytic Lymphoma (SLL) in patients with a 17p deletion. It’s also used for Waldenstrom’s Macroglobulinemia and Marginal Zone Lymphoma after specific therapies.